nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefotaxime—SLC22A7—Fluorouracil—urinary bladder cancer	0.246	0.37	CbGbCtD
Cefotaxime—SLC22A11—Methotrexate—urinary bladder cancer	0.142	0.214	CbGbCtD
Cefotaxime—SLC22A7—Methotrexate—urinary bladder cancer	0.136	0.204	CbGbCtD
Cefotaxime—SLC22A8—Methotrexate—urinary bladder cancer	0.0829	0.125	CbGbCtD
Cefotaxime—SLC22A6—Methotrexate—urinary bladder cancer	0.0577	0.0868	CbGbCtD
Cefotaxime—SLC22A8—urine—urinary bladder cancer	0.00787	0.193	CbGeAlD
Cefotaxime—SLC22A11—renal system—urinary bladder cancer	0.00341	0.0837	CbGeAlD
Cefotaxime—SLC22A7—renal system—urinary bladder cancer	0.00333	0.0817	CbGeAlD
Cefotaxime—SLC15A1—epithelium—urinary bladder cancer	0.00289	0.0708	CbGeAlD
Cefotaxime—SLC22A8—prostate gland—urinary bladder cancer	0.00282	0.0693	CbGeAlD
Cefotaxime—SLC22A11—female reproductive system—urinary bladder cancer	0.00273	0.067	CbGeAlD
Cefotaxime—SLC15A1—renal system—urinary bladder cancer	0.00268	0.0656	CbGeAlD
Cefotaxime—SLC15A2—prostate gland—urinary bladder cancer	0.00246	0.0602	CbGeAlD
Cefotaxime—SLC15A2—seminal vesicle—urinary bladder cancer	0.00208	0.0509	CbGeAlD
Cefotaxime—SLC15A1—vagina—urinary bladder cancer	0.00194	0.0475	CbGeAlD
Cefotaxime—SLC22A8—renal system—urinary bladder cancer	0.00193	0.0472	CbGeAlD
Cefotaxime—SLC15A2—renal system—urinary bladder cancer	0.00167	0.041	CbGeAlD
Cefotaxime—SLC15A2—urethra—urinary bladder cancer	0.00164	0.0403	CbGeAlD
Cefotaxime—Haemolytic anaemia—Cisplatin—urinary bladder cancer	0.0014	0.00479	CcSEcCtD
Cefotaxime—Dermatitis bullous—Fluorouracil—urinary bladder cancer	0.00139	0.00477	CcSEcCtD
Cefotaxime—Nausea—Valrubicin—urinary bladder cancer	0.00136	0.00464	CcSEcCtD
Cefotaxime—Pain—Mitomycin—urinary bladder cancer	0.00134	0.00461	CcSEcCtD
Cefotaxime—SLC15A2—female reproductive system—urinary bladder cancer	0.00134	0.0329	CbGeAlD
Cefotaxime—Feeling abnormal—Mitomycin—urinary bladder cancer	0.0013	0.00444	CcSEcCtD
Cefotaxime—Body temperature increased—Mitomycin—urinary bladder cancer	0.00124	0.00426	CcSEcCtD
Cefotaxime—Renal failure—Thiotepa—urinary bladder cancer	0.00122	0.00417	CcSEcCtD
Cefotaxime—Toxic epidermal necrolysis—Gemcitabine—urinary bladder cancer	0.00122	0.00417	CcSEcCtD
Cefotaxime—SLC15A2—vagina—urinary bladder cancer	0.00121	0.0297	CbGeAlD
Cefotaxime—Jaundice—Thiotepa—urinary bladder cancer	0.00121	0.00414	CcSEcCtD
Cefotaxime—Cefdinir—MPO—urinary bladder cancer	0.00118	0.502	CrCbGaD
Cefotaxime—Cefaclor—MPO—urinary bladder cancer	0.00117	0.498	CrCbGaD
Cefotaxime—Agranulocytosis—Thiotepa—urinary bladder cancer	0.00116	0.00396	CcSEcCtD
Cefotaxime—Bronchospasm—Gemcitabine—urinary bladder cancer	0.00115	0.00394	CcSEcCtD
Cefotaxime—Eosinophilia—Fluorouracil—urinary bladder cancer	0.00114	0.0039	CcSEcCtD
Cefotaxime—Haemoglobin—Thiotepa—urinary bladder cancer	0.00112	0.00383	CcSEcCtD
Cefotaxime—Haemorrhage—Thiotepa—urinary bladder cancer	0.00111	0.00381	CcSEcCtD
Cefotaxime—Neutropenia—Gemcitabine—urinary bladder cancer	0.00109	0.00375	CcSEcCtD
Cefotaxime—Diarrhoea—Mitomycin—urinary bladder cancer	0.00108	0.00369	CcSEcCtD
Cefotaxime—Liver injury—Epirubicin—urinary bladder cancer	0.00106	0.00363	CcSEcCtD
Cefotaxime—Toxic epidermal necrolysis—Etoposide—urinary bladder cancer	0.00104	0.00356	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Gemcitabine—urinary bladder cancer	0.00103	0.00354	CcSEcCtD
Cefotaxime—Renal failure—Gemcitabine—urinary bladder cancer	0.00103	0.00351	CcSEcCtD
Cefotaxime—Vomiting—Mitomycin—urinary bladder cancer	0.001	0.00342	CcSEcCtD
Cefotaxime—Arrhythmia—Thiotepa—urinary bladder cancer	0.000994	0.00341	CcSEcCtD
Cefotaxime—Rash—Mitomycin—urinary bladder cancer	0.000991	0.0034	CcSEcCtD
Cefotaxime—Dermatitis—Mitomycin—urinary bladder cancer	0.00099	0.00339	CcSEcCtD
Cefotaxime—Headache—Mitomycin—urinary bladder cancer	0.000985	0.00337	CcSEcCtD
Cefotaxime—Bronchospasm—Etoposide—urinary bladder cancer	0.000982	0.00337	CcSEcCtD
Cefotaxime—Liver injury—Doxorubicin—urinary bladder cancer	0.000981	0.00336	CcSEcCtD
Cefotaxime—Agranulocytosis—Gemcitabine—urinary bladder cancer	0.000973	0.00333	CcSEcCtD
Cefotaxime—Agranulocytosis—Fluorouracil—urinary bladder cancer	0.000957	0.00328	CcSEcCtD
Cefotaxime—Renal failure—Cisplatin—urinary bladder cancer	0.000955	0.00327	CcSEcCtD
Cefotaxime—Vaginal inflammation—Methotrexate—urinary bladder cancer	0.000953	0.00327	CcSEcCtD
Cefotaxime—Haemoglobin—Gemcitabine—urinary bladder cancer	0.000941	0.00322	CcSEcCtD
Cefotaxime—Haemorrhage—Gemcitabine—urinary bladder cancer	0.000936	0.00321	CcSEcCtD
Cefotaxime—Neutropenia—Etoposide—urinary bladder cancer	0.000934	0.0032	CcSEcCtD
Cefotaxime—Nausea—Mitomycin—urinary bladder cancer	0.000934	0.0032	CcSEcCtD
Cefotaxime—Haemoglobin—Fluorouracil—urinary bladder cancer	0.000925	0.00317	CcSEcCtD
Cefotaxime—Haemorrhage—Fluorouracil—urinary bladder cancer	0.00092	0.00315	CcSEcCtD
Cefotaxime—Vaginal infection—Methotrexate—urinary bladder cancer	0.0009	0.00308	CcSEcCtD
Cefotaxime—Aplastic anaemia—Methotrexate—urinary bladder cancer	0.000895	0.00307	CcSEcCtD
Cefotaxime—Vaginal inflammation—Epirubicin—urinary bladder cancer	0.000892	0.00306	CcSEcCtD
Cefotaxime—Erythema multiforme—Gemcitabine—urinary bladder cancer	0.000885	0.00303	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Etoposide—urinary bladder cancer	0.000883	0.00302	CcSEcCtD
Cefotaxime—Renal failure—Etoposide—urinary bladder cancer	0.000875	0.003	CcSEcCtD
Cefotaxime—Jaundice—Etoposide—urinary bladder cancer	0.000868	0.00297	CcSEcCtD
Cefotaxime—Leukopenia—Thiotepa—urinary bladder cancer	0.000867	0.00297	CcSEcCtD
Cefotaxime—Colitis—Epirubicin—urinary bladder cancer	0.000857	0.00293	CcSEcCtD
Cefotaxime—Candida infection—Epirubicin—urinary bladder cancer	0.000852	0.00292	CcSEcCtD
Cefotaxime—Vaginal infection—Epirubicin—urinary bladder cancer	0.000842	0.00289	CcSEcCtD
Cefotaxime—Convulsion—Thiotepa—urinary bladder cancer	0.000839	0.00288	CcSEcCtD
Cefotaxime—Aplastic anaemia—Epirubicin—urinary bladder cancer	0.000838	0.00287	CcSEcCtD
Cefotaxime—Arrhythmia—Gemcitabine—urinary bladder cancer	0.000836	0.00286	CcSEcCtD
Cefotaxime—Agranulocytosis—Etoposide—urinary bladder cancer	0.000831	0.00285	CcSEcCtD
Cefotaxime—Vaginal inflammation—Doxorubicin—urinary bladder cancer	0.000826	0.00283	CcSEcCtD
Cefotaxime—Arrhythmia—Fluorouracil—urinary bladder cancer	0.000822	0.00282	CcSEcCtD
Cefotaxime—Colitis—Doxorubicin—urinary bladder cancer	0.000793	0.00272	CcSEcCtD
Cefotaxime—Candida infection—Doxorubicin—urinary bladder cancer	0.000788	0.0027	CcSEcCtD
Cefotaxime—SLC15A2—lymph node—urinary bladder cancer	0.000784	0.0192	CbGeAlD
Cefotaxime—Arrhythmia—Cisplatin—urinary bladder cancer	0.000779	0.00267	CcSEcCtD
Cefotaxime—Vaginal infection—Doxorubicin—urinary bladder cancer	0.000779	0.00267	CcSEcCtD
Cefotaxime—Aplastic anaemia—Doxorubicin—urinary bladder cancer	0.000775	0.00266	CcSEcCtD
Cefotaxime—Thrombocytopenia—Thiotepa—urinary bladder cancer	0.000774	0.00265	CcSEcCtD
Cefotaxime—Ill-defined disorder—Gemcitabine—urinary bladder cancer	0.000756	0.00259	CcSEcCtD
Cefotaxime—Erythema multiforme—Etoposide—urinary bladder cancer	0.000756	0.00259	CcSEcCtD
Cefotaxime—Hepatic function abnormal—Epirubicin—urinary bladder cancer	0.000741	0.00254	CcSEcCtD
Cefotaxime—Malaise—Gemcitabine—urinary bladder cancer	0.000735	0.00252	CcSEcCtD
Cefotaxime—Leukopenia—Gemcitabine—urinary bladder cancer	0.000729	0.0025	CcSEcCtD
Cefotaxime—Leukopenia—Fluorouracil—urinary bladder cancer	0.000717	0.00246	CcSEcCtD
Cefotaxime—Ill-defined disorder—Cisplatin—urinary bladder cancer	0.000705	0.00241	CcSEcCtD
Cefotaxime—Convulsion—Fluorouracil—urinary bladder cancer	0.000694	0.00238	CcSEcCtD
Cefotaxime—Hepatic function abnormal—Doxorubicin—urinary bladder cancer	0.000686	0.00235	CcSEcCtD
Cefotaxime—Discomfort—Gemcitabine—urinary bladder cancer	0.000685	0.00235	CcSEcCtD
Cefotaxime—Malaise—Cisplatin—urinary bladder cancer	0.000685	0.00235	CcSEcCtD
Cefotaxime—Renal impairment—Epirubicin—urinary bladder cancer	0.000681	0.00233	CcSEcCtD
Cefotaxime—Leukopenia—Cisplatin—urinary bladder cancer	0.00068	0.00233	CcSEcCtD
Cefotaxime—Dermatitis bullous—Epirubicin—urinary bladder cancer	0.000678	0.00232	CcSEcCtD
Cefotaxime—Pain—Thiotepa—urinary bladder cancer	0.000676	0.00232	CcSEcCtD
Cefotaxime—Discomfort—Fluorouracil—urinary bladder cancer	0.000674	0.00231	CcSEcCtD
Cefotaxime—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.000665	0.00228	CcSEcCtD
Cefotaxime—Convulsion—Cisplatin—urinary bladder cancer	0.000658	0.00225	CcSEcCtD
Cefotaxime—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.000654	0.00224	CcSEcCtD
Cefotaxime—Feeling abnormal—Thiotepa—urinary bladder cancer	0.000652	0.00223	CcSEcCtD
Cefotaxime—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.000651	0.00223	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.000646	0.00221	CcSEcCtD
Cefotaxime—Ill-defined disorder—Etoposide—urinary bladder cancer	0.000646	0.00221	CcSEcCtD
Cefotaxime—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.00064	0.00219	CcSEcCtD
Cefotaxime—Discomfort—Cisplatin—urinary bladder cancer	0.000639	0.00219	CcSEcCtD
Cefotaxime—Renal impairment—Doxorubicin—urinary bladder cancer	0.00063	0.00216	CcSEcCtD
Cefotaxime—Urticaria—Thiotepa—urinary bladder cancer	0.000628	0.00215	CcSEcCtD
Cefotaxime—Malaise—Etoposide—urinary bladder cancer	0.000628	0.00215	CcSEcCtD
Cefotaxime—Dermatitis bullous—Doxorubicin—urinary bladder cancer	0.000627	0.00215	CcSEcCtD
Cefotaxime—Body temperature increased—Thiotepa—urinary bladder cancer	0.000625	0.00214	CcSEcCtD
Cefotaxime—Abdominal pain—Thiotepa—urinary bladder cancer	0.000625	0.00214	CcSEcCtD
Cefotaxime—Toxic epidermal necrolysis—Methotrexate—urinary bladder cancer	0.000623	0.00214	CcSEcCtD
Cefotaxime—Leukopenia—Etoposide—urinary bladder cancer	0.000623	0.00213	CcSEcCtD
Cefotaxime—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.00062	0.00212	CcSEcCtD
Cefotaxime—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.000607	0.00208	CcSEcCtD
Cefotaxime—Convulsion—Etoposide—urinary bladder cancer	0.000603	0.00207	CcSEcCtD
Cefotaxime—Eosinophilia—Methotrexate—urinary bladder cancer	0.000592	0.00203	CcSEcCtD
Cefotaxime—Discomfort—Etoposide—urinary bladder cancer	0.000585	0.00201	CcSEcCtD
Cefotaxime—Toxic epidermal necrolysis—Epirubicin—urinary bladder cancer	0.000583	0.002	CcSEcCtD
Cefotaxime—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000582	0.002	CcSEcCtD
Cefotaxime—Pain—Gemcitabine—urinary bladder cancer	0.000569	0.00195	CcSEcCtD
Cefotaxime—Anaphylactic shock—Etoposide—urinary bladder cancer	0.000568	0.00195	CcSEcCtD
Cefotaxime—Neutropenia—Methotrexate—urinary bladder cancer	0.000559	0.00192	CcSEcCtD
Cefotaxime—Pruritus—Thiotepa—urinary bladder cancer	0.000559	0.00192	CcSEcCtD
Cefotaxime—Pain—Fluorouracil—urinary bladder cancer	0.000559	0.00192	CcSEcCtD
Cefotaxime—Thrombocytopenia—Etoposide—urinary bladder cancer	0.000556	0.0019	CcSEcCtD
Cefotaxime—Eosinophilia—Epirubicin—urinary bladder cancer	0.000554	0.0019	CcSEcCtD
Cefotaxime—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000548	0.00188	CcSEcCtD
Cefotaxime—Diarrhoea—Thiotepa—urinary bladder cancer	0.000541	0.00185	CcSEcCtD
Cefotaxime—Toxic epidermal necrolysis—Doxorubicin—urinary bladder cancer	0.00054	0.00185	CcSEcCtD
Cefotaxime—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000539	0.00185	CcSEcCtD
Cefotaxime—Pain—Cisplatin—urinary bladder cancer	0.00053	0.00182	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Methotrexate—urinary bladder cancer	0.000529	0.00181	CcSEcCtD
Cefotaxime—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000526	0.0018	CcSEcCtD
Cefotaxime—Renal failure—Methotrexate—urinary bladder cancer	0.000524	0.0018	CcSEcCtD
Cefotaxime—Neutropenia—Epirubicin—urinary bladder cancer	0.000523	0.00179	CcSEcCtD
Cefotaxime—Urticaria—Fluorouracil—urinary bladder cancer	0.000519	0.00178	CcSEcCtD
Cefotaxime—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000517	0.00177	CcSEcCtD
Cefotaxime—Eosinophilia—Doxorubicin—urinary bladder cancer	0.000513	0.00176	CcSEcCtD
Cefotaxime—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000511	0.00175	CcSEcCtD
Cefotaxime—Vomiting—Thiotepa—urinary bladder cancer	0.000503	0.00172	CcSEcCtD
Cefotaxime—Rash—Thiotepa—urinary bladder cancer	0.000498	0.00171	CcSEcCtD
Cefotaxime—Dermatitis—Thiotepa—urinary bladder cancer	0.000498	0.00171	CcSEcCtD
Cefotaxime—Agranulocytosis—Methotrexate—urinary bladder cancer	0.000498	0.00171	CcSEcCtD
Cefotaxime—Headache—Thiotepa—urinary bladder cancer	0.000495	0.0017	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	0.000495	0.0017	CcSEcCtD
Cefotaxime—Renal failure—Epirubicin—urinary bladder cancer	0.000491	0.00168	CcSEcCtD
Cefotaxime—Body temperature increased—Cisplatin—urinary bladder cancer	0.00049	0.00168	CcSEcCtD
Cefotaxime—Jaundice—Epirubicin—urinary bladder cancer	0.000487	0.00167	CcSEcCtD
Cefotaxime—Pain—Etoposide—urinary bladder cancer	0.000486	0.00166	CcSEcCtD
Cefotaxime—Neutropenia—Doxorubicin—urinary bladder cancer	0.000484	0.00166	CcSEcCtD
Cefotaxime—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000482	0.00165	CcSEcCtD
Cefotaxime—Haemoglobin—Methotrexate—urinary bladder cancer	0.000481	0.00165	CcSEcCtD
Cefotaxime—Haemorrhage—Methotrexate—urinary bladder cancer	0.000479	0.00164	CcSEcCtD
Cefotaxime—Hepatitis—Methotrexate—urinary bladder cancer	0.000479	0.00164	CcSEcCtD
Cefotaxime—Pruritus—Gemcitabine—urinary bladder cancer	0.000471	0.00161	CcSEcCtD
Cefotaxime—Nausea—Thiotepa—urinary bladder cancer	0.00047	0.00161	CcSEcCtD
Cefotaxime—Feeling abnormal—Etoposide—urinary bladder cancer	0.000468	0.0016	CcSEcCtD
Cefotaxime—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000466	0.0016	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000464	0.00159	CcSEcCtD
Cefotaxime—Pruritus—Fluorouracil—urinary bladder cancer	0.000463	0.00158	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.000458	0.00157	CcSEcCtD
Cefotaxime—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000457	0.00156	CcSEcCtD
Cefotaxime—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000455	0.00156	CcSEcCtD
Cefotaxime—Renal failure—Doxorubicin—urinary bladder cancer	0.000454	0.00156	CcSEcCtD
Cefotaxime—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000453	0.00155	CcSEcCtD
Cefotaxime—Urticaria—Etoposide—urinary bladder cancer	0.000451	0.00155	CcSEcCtD
Cefotaxime—Haemoglobin—Epirubicin—urinary bladder cancer	0.00045	0.00154	CcSEcCtD
Cefotaxime—Jaundice—Doxorubicin—urinary bladder cancer	0.00045	0.00154	CcSEcCtD
Cefotaxime—Body temperature increased—Etoposide—urinary bladder cancer	0.000449	0.00154	CcSEcCtD
Cefotaxime—Abdominal pain—Etoposide—urinary bladder cancer	0.000449	0.00154	CcSEcCtD
Cefotaxime—Hepatitis—Epirubicin—urinary bladder cancer	0.000448	0.00154	CcSEcCtD
Cefotaxime—Haemorrhage—Epirubicin—urinary bladder cancer	0.000448	0.00154	CcSEcCtD
Cefotaxime—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000447	0.00153	CcSEcCtD
Cefotaxime—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000431	0.00148	CcSEcCtD
Cefotaxime—Diarrhoea—Cisplatin—urinary bladder cancer	0.000424	0.00145	CcSEcCtD
Cefotaxime—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000424	0.00145	CcSEcCtD
Cefotaxime—Vomiting—Gemcitabine—urinary bladder cancer	0.000423	0.00145	CcSEcCtD
Cefotaxime—Rash—Gemcitabine—urinary bladder cancer	0.000419	0.00144	CcSEcCtD
Cefotaxime—Dermatitis—Gemcitabine—urinary bladder cancer	0.000419	0.00144	CcSEcCtD
Cefotaxime—Hypersensitivity—Etoposide—urinary bladder cancer	0.000418	0.00143	CcSEcCtD
Cefotaxime—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000417	0.00143	CcSEcCtD
Cefotaxime—Headache—Gemcitabine—urinary bladder cancer	0.000417	0.00143	CcSEcCtD
Cefotaxime—Vomiting—Fluorouracil—urinary bladder cancer	0.000416	0.00142	CcSEcCtD
Cefotaxime—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000415	0.00142	CcSEcCtD
Cefotaxime—Hepatitis—Doxorubicin—urinary bladder cancer	0.000415	0.00142	CcSEcCtD
Cefotaxime—Rash—Fluorouracil—urinary bladder cancer	0.000412	0.00141	CcSEcCtD
Cefotaxime—Dermatitis—Fluorouracil—urinary bladder cancer	0.000412	0.00141	CcSEcCtD
Cefotaxime—Headache—Fluorouracil—urinary bladder cancer	0.00041	0.0014	CcSEcCtD
Cefotaxime—Pruritus—Etoposide—urinary bladder cancer	0.000402	0.00138	CcSEcCtD
Cefotaxime—Arrhythmia—Epirubicin—urinary bladder cancer	0.0004	0.00137	CcSEcCtD
Cefotaxime—Nausea—Gemcitabine—urinary bladder cancer	0.000395	0.00135	CcSEcCtD
Cefotaxime—Vomiting—Cisplatin—urinary bladder cancer	0.000394	0.00135	CcSEcCtD
Cefotaxime—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000392	0.00134	CcSEcCtD
Cefotaxime—Rash—Cisplatin—urinary bladder cancer	0.000391	0.00134	CcSEcCtD
Cefotaxime—Dermatitis—Cisplatin—urinary bladder cancer	0.00039	0.00134	CcSEcCtD
Cefotaxime—Diarrhoea—Etoposide—urinary bladder cancer	0.000389	0.00133	CcSEcCtD
Cefotaxime—Nausea—Fluorouracil—urinary bladder cancer	0.000388	0.00133	CcSEcCtD
Cefotaxime—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000387	0.00132	CcSEcCtD
Cefotaxime—Malaise—Methotrexate—urinary bladder cancer	0.000376	0.00129	CcSEcCtD
Cefotaxime—Leukopenia—Methotrexate—urinary bladder cancer	0.000373	0.00128	CcSEcCtD
Cefotaxime—Arrhythmia—Doxorubicin—urinary bladder cancer	0.00037	0.00127	CcSEcCtD
Cefotaxime—Nausea—Cisplatin—urinary bladder cancer	0.000368	0.00126	CcSEcCtD
Cefotaxime—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000362	0.00124	CcSEcCtD
Cefotaxime—Convulsion—Methotrexate—urinary bladder cancer	0.000361	0.00124	CcSEcCtD
Cefotaxime—Vomiting—Etoposide—urinary bladder cancer	0.000361	0.00124	CcSEcCtD
Cefotaxime—Rash—Etoposide—urinary bladder cancer	0.000358	0.00123	CcSEcCtD
Cefotaxime—Dermatitis—Etoposide—urinary bladder cancer	0.000358	0.00123	CcSEcCtD
Cefotaxime—Headache—Etoposide—urinary bladder cancer	0.000356	0.00122	CcSEcCtD
Cefotaxime—Malaise—Epirubicin—urinary bladder cancer	0.000352	0.00121	CcSEcCtD
Cefotaxime—Discomfort—Methotrexate—urinary bladder cancer	0.000351	0.0012	CcSEcCtD
Cefotaxime—Leukopenia—Epirubicin—urinary bladder cancer	0.000349	0.0012	CcSEcCtD
Cefotaxime—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.00034	0.00117	CcSEcCtD
Cefotaxime—Convulsion—Epirubicin—urinary bladder cancer	0.000338	0.00116	CcSEcCtD
Cefotaxime—Nausea—Etoposide—urinary bladder cancer	0.000337	0.00116	CcSEcCtD
Cefotaxime—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000335	0.00115	CcSEcCtD
Cefotaxime—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000333	0.00114	CcSEcCtD
Cefotaxime—Discomfort—Epirubicin—urinary bladder cancer	0.000328	0.00112	CcSEcCtD
Cefotaxime—Malaise—Doxorubicin—urinary bladder cancer	0.000325	0.00112	CcSEcCtD
Cefotaxime—Leukopenia—Doxorubicin—urinary bladder cancer	0.000323	0.00111	CcSEcCtD
Cefotaxime—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000318	0.00109	CcSEcCtD
Cefotaxime—Shock—Epirubicin—urinary bladder cancer	0.000313	0.00107	CcSEcCtD
Cefotaxime—Convulsion—Doxorubicin—urinary bladder cancer	0.000313	0.00107	CcSEcCtD
Cefotaxime—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000312	0.00107	CcSEcCtD
Cefotaxime—Discomfort—Doxorubicin—urinary bladder cancer	0.000304	0.00104	CcSEcCtD
Cefotaxime—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000295	0.00101	CcSEcCtD
Cefotaxime—Pain—Methotrexate—urinary bladder cancer	0.000291	0.000997	CcSEcCtD
Cefotaxime—Shock—Doxorubicin—urinary bladder cancer	0.00029	0.000993	CcSEcCtD
Cefotaxime—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000288	0.000988	CcSEcCtD
Cefotaxime—Feeling abnormal—Methotrexate—urinary bladder cancer	0.00028	0.00096	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000278	0.000953	CcSEcCtD
Cefotaxime—Pain—Epirubicin—urinary bladder cancer	0.000272	0.000933	CcSEcCtD
Cefotaxime—Urticaria—Methotrexate—urinary bladder cancer	0.00027	0.000926	CcSEcCtD
Cefotaxime—Body temperature increased—Methotrexate—urinary bladder cancer	0.000269	0.000921	CcSEcCtD
Cefotaxime—Abdominal pain—Methotrexate—urinary bladder cancer	0.000269	0.000921	CcSEcCtD
Cefotaxime—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000262	0.000899	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.00026	0.000892	CcSEcCtD
Cefotaxime—Urticaria—Epirubicin—urinary bladder cancer	0.000253	0.000866	CcSEcCtD
Cefotaxime—Pain—Doxorubicin—urinary bladder cancer	0.000252	0.000863	CcSEcCtD
Cefotaxime—Body temperature increased—Epirubicin—urinary bladder cancer	0.000252	0.000862	CcSEcCtD
Cefotaxime—Abdominal pain—Epirubicin—urinary bladder cancer	0.000252	0.000862	CcSEcCtD
Cefotaxime—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000251	0.000859	CcSEcCtD
Cefotaxime—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000243	0.000832	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000241	0.000825	CcSEcCtD
Cefotaxime—Pruritus—Methotrexate—urinary bladder cancer	0.000241	0.000825	CcSEcCtD
Cefotaxime—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000235	0.000804	CcSEcCtD
Cefotaxime—Urticaria—Doxorubicin—urinary bladder cancer	0.000234	0.000802	CcSEcCtD
Cefotaxime—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000233	0.000798	CcSEcCtD
Cefotaxime—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000233	0.000798	CcSEcCtD
Cefotaxime—Diarrhoea—Methotrexate—urinary bladder cancer	0.000233	0.000797	CcSEcCtD
Cefotaxime—Pruritus—Epirubicin—urinary bladder cancer	0.000225	0.000772	CcSEcCtD
Cefotaxime—Diarrhoea—Epirubicin—urinary bladder cancer	0.000218	0.000746	CcSEcCtD
Cefotaxime—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000217	0.000743	CcSEcCtD
Cefotaxime—Vomiting—Methotrexate—urinary bladder cancer	0.000216	0.000741	CcSEcCtD
Cefotaxime—Rash—Methotrexate—urinary bladder cancer	0.000214	0.000735	CcSEcCtD
Cefotaxime—Dermatitis—Methotrexate—urinary bladder cancer	0.000214	0.000734	CcSEcCtD
Cefotaxime—Headache—Methotrexate—urinary bladder cancer	0.000213	0.00073	CcSEcCtD
Cefotaxime—Pruritus—Doxorubicin—urinary bladder cancer	0.000208	0.000714	CcSEcCtD
Cefotaxime—Vomiting—Epirubicin—urinary bladder cancer	0.000202	0.000693	CcSEcCtD
Cefotaxime—Nausea—Methotrexate—urinary bladder cancer	0.000202	0.000692	CcSEcCtD
Cefotaxime—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000202	0.00069	CcSEcCtD
Cefotaxime—Rash—Epirubicin—urinary bladder cancer	0.000201	0.000688	CcSEcCtD
Cefotaxime—Dermatitis—Epirubicin—urinary bladder cancer	0.000201	0.000687	CcSEcCtD
Cefotaxime—Headache—Epirubicin—urinary bladder cancer	0.000199	0.000683	CcSEcCtD
Cefotaxime—Nausea—Epirubicin—urinary bladder cancer	0.000189	0.000648	CcSEcCtD
Cefotaxime—Vomiting—Doxorubicin—urinary bladder cancer	0.000187	0.000642	CcSEcCtD
Cefotaxime—Rash—Doxorubicin—urinary bladder cancer	0.000186	0.000636	CcSEcCtD
Cefotaxime—Dermatitis—Doxorubicin—urinary bladder cancer	0.000186	0.000636	CcSEcCtD
Cefotaxime—Headache—Doxorubicin—urinary bladder cancer	0.000185	0.000632	CcSEcCtD
Cefotaxime—Nausea—Doxorubicin—urinary bladder cancer	0.000175	0.000599	CcSEcCtD
